Phenelzine: Acute toxic cytolytic hepatitis: case report

June 2019
Reactions Weekly;6/22/2019, Vol. 1758 Issue 1, p279
No abstract available.


Related Articles

  • Fulminant Hepatic Failure. Fingerote, Robert J.; Bain, Vincent G. // American Journal of Gastroenterology;Jul1993, Vol. 88 Issue 7, p1000 

    Fulminant hepatic failure (FHF) is defined as acute liver failure with hepatic encephalopathy in patients with no history or stigmata of chronic liver disease. Historically, its prognosis was extremely poor. However, the emergence of orthotopic liver transplantation as a viable form of therapy...

  • USE OF TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT AS A BRIDGE TO TRANSPLANTATION IN FULMINANT HEPATIC FAILURE DUE TO BUDD-CHIARI SYNDROME. Shrestha, Roshan; Durham, Janette D.; Wachs, Michael; Bilir, Bahri M.; Kam, Igal; Trouillot, Thomas; Everson, Gregory T. // American Journal of Gastroenterology;Dec1997, Vol. 92 Issue 12, p2304 

    We report a case of fulminant hepatic failure in a 55-yr-old man due to Budd-Chiari syndrome in the setting of polycythemia rubra vera. The patient presented with acute hepatic failure, which rapidly progressed to grade IV hepatic encephalopathy. Placement of a transjugular intrahepatic...

  • Liver Transplant in a Patient under Methylphenidate Therapy: A Case Report and Review of the Literature. Tong, Hoi Y.; Díaz, Carmen; Collantes, Elena; Medrano, Nicolás; Borobia, Alberto M.; Jara, Paloma; Ramírez, Elena // Case Reports in Pediatrics;1/22/2015, Vol. 2015, p1 

    Background. Methylphenidate (MPH) is widely used in treating children with attention-deficit-hyperactivity disorder. Hepatotoxicity is a rare phenomenon; only few cases are described with no liver failure. Case. We report on the case of a 12-year-old boy who received MPH for...

  • Acute liver failure caused by severe acute hepatitis B: a case series from a multi-center investigation. Chun-ya Wang; Pan Zhao; Wei-wei Liu // Annals of Clinical Microbiology & Antimicrobials;2014, Vol. 13 Issue 1, p1 

    Background Few data can be available regarding acute liver failure (ALF) caused by severe acute hepatitis B up to now. This study aims to report such cases from China. Findings We conducted a multi-center investigation on ALF from 7 tertiary hospitals in different areas of China. A total of 11...

  • Survival of patient with late onset hepatic failure by living-related liver transplantation from maternal donor with incompatible blood type. Kojima, Akira; Takagi, Hitoshi; Abe, Takehiko; Sakurai, Seiji; Sohara, Naondo; Kakizaki, Satoru; Nagamine, Takeaki; Mori, Masatomo; Matsunami, Masatoshi; Ikegami, Toshihiko; Hashikura, Yasuhiko; Kawasaki, Seiji; Makuuchi, Masatoshi; Kojima, A; Takagi, H; Abe, T; Sakurai, S; Sohara, N; Kakizaki, S; Nagamine, T // Journal of Gastroenterology;1998, Vol. 33 Issue 6, p899 

    A 14-year-old girl with blood type B with late onset hepatic failure (LOHF) of unknown cause has survived through living-related liver transplantation (LRLT). No hepatitis virus, including HAV, HBV, HCV, and HGV, was positive at the onset of LOHF. Autoimmune hepatitis was thought to be the cause...

  • A Comparison of Paracentesis and Transjugular Intrahepatic Portosystemic Shunting in Patients with Ascites. Rössle, Martin; Ochs, Andreas; Gülberg, Veit; Siegerstetter, Volker; Holl, Joseph; Deibert, Peter; Olschewski, Manfred; Reiser, Maximilian; Gerbes, Alexander L. // New England Journal of Medicine;06/08/2000, Vol. 342 Issue 23, p1701 

    Background: In patients with cirrhosis and ascites, creation of a transjugular intrahepatic portosystemic shunt may reduce the ascites and improve renal function. However, the benefit of this procedure as compared with that of large-volume paracentesis is uncertain. Methods: We randomly assigned...

  • Fulminant hepatic failure in woman with iron and non-steroidal anti-inflammatory drug intoxication. Magdalan, Jan; Zawadzki, Marcin; Sozański, Tomasz // Human & Experimental Toxicology;Aug2011, Vol. 30 Issue 8, p1106 

    A 17-year-old, previously healthy female ingested 16,000 mg iron sulphate (96.15 mg of iron ions per kg of b.wt.) with a suicidal intent. The patient was admitted to a toxicology unit 10 hours after the drug ingestion. Serum iron concentration at admission was 2351 μg% (421.0 μmol/L). In...

  • Retrasplante hepático. Primer reporte en México. Mendoza-Sánchez, Federico; Herrera-Rodríguez, Roberto; López-Bañuelos, Carlos; Romero-Beltrán, Omar; Navarro-López, Ricardo; Ramírez-Ramos, José // Cirugia y Cirujanos;ene/feb2009, Vol. 77 Issue 1, p65 

    Background: The only therapeutic option for patients with hepatic graft failure is retransplant. In Mexico, the number of hepatic transplants is scarce and is even less for retransplants. There are no reports of patients with good results after hepatic retransplant. Here we present the first...

  • Reversibility of hepatic encephalopathy after liver transplantation. Atluri, Dileep K.; Asgeri, Mehrdad; Mullen, Kevin D. // Metabolic Brain Disease;Mar2010, Vol. 25 Issue 1, p111 

    Until the advent of Liver transplantation, it was widely believed that Hepatic Encephalopathy (HE) was usually reversible. The exceptions were the so called “Acquired Hepatocerebral Degeneration cases” which were considered irreversible. Paradoxically, it seems, with liver...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics